

Proprio
The next generation of surgical navigation technology
A core tenet of DCVC’s deep tech thesis is that when a strong team has a significant, proprietary data set flowing into a distinct computational advantage, it can advance a traditional industry at a tremendous rate, powering both the slope and speed of innovation.
This is clearly evidenced in our TechMed investment pillar. When we initially invested in Proprio over four years ago, we saw a unique data opportunity, one harnessed to edge AI computing capabilities that will deliver better outcomes for patients in terms of quality, speed, and availability. In surgery, data rivers power a form of physical AI where autonomy and guidance can change how surgeons work. Proprio’s advancements occur in a field that has seen relatively few groundbreaking innovations since the invention of the X‑Ray and CT-scans.
Surgery represents an enormous amount of annual healthcare spend — $100s of billions alone in the U.S. — and directly affects quality-of-life issues for millions of patients. The $60B global spine market focuses on reducing pain and increasing function, yet it still relies on an apprentice-like training system, where the physical dexterity (including hand-eye coordination), education, experience, and stamina of the surgeon are key determinants of success. Spine surgery is very difficult — hence its relatively high variability in outcomes.
Inherent in most spine surgeries is the placement of pedicle screws to anchor surgical implants that sustain spinal alignment. Conventionally this has been a freehand technique guided by feel and occasional fluoroscopic snapshots. This is time-consuming, exposes patients and staff to cancer-causing radiation every time a snapshot to take measurements is needed, and depends heavily on surgeon judgement. Research has shown that freehand screw placement accuracy varies significantly with surgeon experience. Revision rates for spine surgery because outcomes are poor are incredibly high.
Until now.
About 18 months ago, Proprio received FDA 510K clearance for its 3D surgical navigation system, a breakthrough that was akin to a real-time Google Map in guiding a procedure. The company has participated in over 75 live procedures with great results.
Today, Proprio announced that it has received its second FDA clearance for its AI Surgical Guidance Platform, which provides surgical teams with accurate measurements during the surgery. Said plainly, a surgeon will know with certainty whether the procedure has achieved the actual angles and placements required to provide an optimal outcome based on a pre-operative plan and what is learned during the actual surgery. The surgeon will know if they have achieved their goals in real time.
This is not just a breakthrough, it’s a revolution. Surgeons will no longer need to stop a procedure for 15 – 30 minutes to take images. No longer will they leave a patient on an operating room table waiting for an x‑ray or CT machine to be wheeled in. The surgeon will have the most important data to determine the success of the surgery as they are undertaking the procedure itself. To me, this is the first step of delivering a surgical JARVIS, an AI co-pilot that meaningfully supports these highly trained, talented medical professionals.
Here is some of what Proprio’s AI-powered surgical guidance can do for a surgeon:
In essence, Proprio’s AI acts as an ever-watchful assistant, performing continuous measurements and analysis that would be impossible for a human to do in real time. Over time, the ability to collect novel, valuable data easily wins.
Machine learning in a surgical guidance system can contribute to predictive analytics, not only supporting the procedure itself, but learning the relationship between surgical actions and outcomes. This opens the door for AI to suggest optimal implant sizes, predict the spinal alignment after certain corrections, or flag measurements that seem off compared to successful cases in the past.
Surgical guidance systems build on a large data set of “known good” measurements and outcomes, helping to guide surgeons by comparing the current intraoperative measurements to expected targets. Measurements like distances to anatomic landmarks or angles for screw insertion are visually presented to the surgeon rather than manually measured with a ruler or protractor on an X‑ray. The benefit to the surgeon is immediate access to critical measurements without breaking focus — imagine glancing at the surgical field and seeing a number indicating how many degrees of rotation have been corrected so far in a spinal deformity case, or a marker showing the exact entry point for a pedicle screw and the angle in three-dimensional space.
Ultimately Proprio’s pursuit of AI and real time image analysis not only gives surgeons superpowers in visualization during a procedure, but also ensures that measurements are not missed, creating a cognitive advancement for even the most experienced and talented surgeon. This enhances safety and precision. The co-pilot in the surgical guidance system monitors dozens of parameters in split seconds. It double-checks your work and can help deliver unparalleled accuracy, the underlying success measure of an optimal procedure.
One immediate benefit a surgeon could soon see is reduced variability in outcomes. Spine surgery has historically seen a lot of technique variation. But for this to move forward, surgeons must adapt to new ways of operating, which often involves a learning curve. Hospitals are increasingly viewing advanced surgical technology as a must-have for competitive and quality reasons. We are seeing multi-center hospital systems invest in spine robots and intelligent navigation systems. The early adopters often report better efficiencies, which pressures others to follow suit to avoid being left behind. In spine surgery specifically, with an aging population and a high demand for spine procedures, technologies that allow surgeons to do more complex cases safely or to handle more volume (through efficiency) can gain traction quickly.
Proprio is leading the world to better surgery done more easily: its FDA clearances validate its approach and will accelerate its growth. Major congrats to CEO Gabe Jones and the whole team.